April 12, 2020 / By ALARIC DEARMENT A small biotechnology company focused on antiviral drugs that has lately gained prominence in the fight against Covid-19 has added a division of one of Korea’s largest business conglomerates to its growing portfolio of big-ticket biopharma partnerships. San Francisco-based Vir Biotechnology said Thursday that it made a partnership with Songdo, South …